Syros Pharmaceuticals, Inc.

Q2 2023 13F Holders

Symbol
SYRS
CUSIP
87184Q206
Type
Equity
Class
COM NEW
Num filings
56
Total reported value, excl. options
$33.5 M
Manager Report Date Value ($000) Shares Option Type